2 More COVID-19 Vaccines Approved for Emergency Use in India

NEW DELHI: The Central Government on Tuesday approved the emergency use of two more COVID-19 vaccines Covovax and Corbevax and Anti-viral drug Molnupiravir.

Union Health Minister Dr Mansukh Mandaviyq informed that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab Corbevax and anti-Covid pill Molnupiravir for restricted use in emergency situation.

Taking to Twitter to make the announcement, Mandaviya wrote, "Congratulations India Flag of India. Further strengthening the fight against COVID-19, Central Drugs Standard Control Organisation (CDSCO) under the Ministry of Health and Family Welfare has given 3 approvals in a single day for -- CORBEVAX vaccine, COVOVAX vaccine, Anti-viral drug Molnupiravir for restricted use in emergency situation."

With this approval, the number of Covid vaccines which have received emergency use authorisation in the country has increased to eight. Six COVID-19 vaccines -- Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson -- had already received EUA from the Indian drug regulator earlier.